Omapatrilat
- Level
- Commodity
- Parent
- 51433900
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51433909This classification denotes an ace inhibitor with the molecular formula C19H24N2O4S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 36NLI90E7T, chemically known as 7h-pyrido(2,1-b)(1,3)thiazepine-7-carboxylic acid, octahydro-4-(((2s)-2-mercapto-1-oxo-3-phenylpropyl)amino)-5-oxo-, (4s,7s,10as)- but generally known as omapatrilat, which bears US NIH Compound Identifier 126046. European Medicines Agency schedules Omapatrilat in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12450MIG. The term OMAPATRILAT is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 12 No. 2 1999, List 40). OMAPATRILAT is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule omapatrilat under HS 29349990 and SITC 51579. As of Q4 2014, OMAPATRILAT remains the US FDA Preferred Term for this commodity. Omapatrilat bears US NLM identifiers UMLS ID C0663645 and NCI Concept Code C1782. SMILES: S1C2N(C(CCC2)C(=O)O)C(=O)C(NC(=O)C(S)Cc2ccccc2)CC1.
Same parent
Under 51433900 · 37Activities that produce or sell this
KBLI · 8Inherited from family 51430000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.